Overview

Evaluation of the Efficacy and Safety of Oral Roflumilast Versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata

Status:
COMPLETED

Trial end date:
2025-08-20

Target enrollment:

Participant gender:

Summary

Evaluation of the Efficacy and Safety of a drug called Oral Roflumilast versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata.

Phase:

PHASE4

Details

Lead Sponsor:

Cairo University

Treatments:

Roflumilast